THE MINISTER OF THE STATE IN THE MINISTRY OF HEALTH AND FAMILY WELFARE
(DR. ANBUMANI RAMADOSS)
(a)to(g): A statement is laid on the Table of the House.
STATEMENT REFERRED TO IN REPLY TO LOK SABHA STARRED QUESTION NO. 151 FOR 22ND AUGUST, 2007
A report had appeared in the Mint dated 24th July, 2007 (a publication of Hindustan Times) stating that Delhi Medical
Association (DMA) had found that 4 of the 53 drugs samples collected from Bhagirath Place are genuine.However,
DMA on enquiry have confirmed that they have not done any survey in Bhagirath Place during 2004.There are no reports
of IMA to show that 35% of drugs sold in India are fake & pirated.
Â
There are some cases reported of spurious / not of standard quality drugs being marketed in the country. However,
whenever such cases come to light, raids are carried out by the State Drugs Control Department with the help of police
to apprehend the culprit.
Â
 Data Pertaining to 2004-05, 2005-06 and 2006-07 is annexed. The current year data till date is being collected from the states.
Â
Recently, allegedly counterfeit / fake medicines were recovered by the UP Drugs Control along with Police from some parts
of UP like Muzzafarnagar, Ghazibad, Meerut, Agra, Modinagar, etc. Similarly, in Bolangir district in Orissa fake
medicines were detected.
Â
The following measures have been taken by government to check availability of spurious drugs in the country:
Â
A bill has been introduced in this session of Parliament providing for the creation for a Central Drugs Authority for
strengthening the regulatory framework and to have uniform control over the manufacturers of the Drugs.
Â
Another bill is already introduced in Parliament to provide stricter penalties, provision for special courts for speedy trail of
drug related offences, compounding offences authorizing the Police also to file prosecution for drugs related offences and
making all such offences cognizable and non-bailable. The bill is expected to be taken up for consideration and passing
during the current session of Parliament.
Â
Schedule M of the Drugs and Cosmetics Act, 1940, has been amended to make it at par with international standards and it
has been made mandatory for the manufacture of drug for better quality of the products manufactured by them.
Â
Detailed guidelines have been issued to the State Government to undertake focused surveillance over possible movement
of spurious drugs.
Â
Specific training programmes for regulatory officials of state governments on the logistics of intelligence work, prosecutions
etc. have been conducted.